206 related articles for article (PubMed ID: 90129)
21. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulation of relapsing experimental allergic encephalomyelitis.
Lublin FD
Neurology; 1984 Dec; 34(12):1615-7. PubMed ID: 6209597
[TBL] [Abstract][Full Text] [Related]
23. Necessity of continuous antigenic stimulation by the locally retained antigens in chronic relapsing experimental allergic encephalomyelitis.
Tabira T; Itoyama Y; Kuroiwa Y
J Neurol Sci; 1984 Oct; 66(1):97-106. PubMed ID: 6084050
[TBL] [Abstract][Full Text] [Related]
24. Chronic relapsing experimental allergic encephalomyelitis: effect of age at the time of sensitization on clinical course and pathology.
Lassmann H; Wisniewski HM
Acta Neuropathol; 1979 Jul; 47(2):111-6. PubMed ID: 474071
[TBL] [Abstract][Full Text] [Related]
25. Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats.
Keith AB
J Neurol Sci; 1978 Oct; 38(3):317-26. PubMed ID: 569689
[TBL] [Abstract][Full Text] [Related]
26. Chronic progressive experimental allergic encephalomyelitis (EAE) in adult guinea pigs.
Wisniewski HM; Madrid RE
J Neuropathol Exp Neurol; 1983 May; 42(3):243-55. PubMed ID: 6188808
[TBL] [Abstract][Full Text] [Related]
27. [Induction of experimental allergic encephalomyelitis with encephalitogenic myelin proteins from the spinal cord of a bull].
Pleskov VM; Saakian IL; Zhitnukhin IuL
Vopr Med Khim; 1979; 25(4):420-3. PubMed ID: 473681
[TBL] [Abstract][Full Text] [Related]
28. Durability of immune protection against experimental autoimmune encephalomyelitis.
Bernard CC; Mackay IR; Whittingham S; Brous P
Cell Immunol; 1976 Mar; 22(2):297-310. PubMed ID: 58731
[No Abstract] [Full Text] [Related]
29. Immunologic activity of myelin basic protein in strain 2 and strain 13 guinea pigs.
Kies MW; Driscoll BF; Lisak RP; Alvord EC
J Immunol; 1975 Jul; 115(1):75-9. PubMed ID: 50359
[TBL] [Abstract][Full Text] [Related]
30. Protection against experimental allergic encephalomyelitis.
Teitelbaum D; Webb C; Meshorer A; Arnon R; Sela M
Nature; 1972 Dec; 240(5383):564-6. PubMed ID: 4119624
[No Abstract] [Full Text] [Related]
31. Chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs: cell-mediated immunity and IgG isoelectric focusing in myelin basic protein-liposome-treated and untreated animals.
St Louis J; Gilbert JJ; Moscarello MA; Strejan GH
J Neuroimmunol; 1989 Feb; 21(2-3):137-47. PubMed ID: 2463997
[TBL] [Abstract][Full Text] [Related]
32. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
Panitch H; Ciccone C
Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
[TBL] [Abstract][Full Text] [Related]
33. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis.
Raine CS; Traugott U; Stone SH
Science; 1978 Aug; 201(4354):445-8. PubMed ID: 78524
[TBL] [Abstract][Full Text] [Related]
34. NMR studies in the relapsing experimental allergic encephalomyelitis (EAE) model of multiple sclerosis in the strain 13 guinea pig.
Karlik SJ; Wong C; Gilbert JJ; Noseworthy JH
Magn Reson Imaging; 1989; 7(5):463-73. PubMed ID: 2481798
[TBL] [Abstract][Full Text] [Related]
35. The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes.
Hosein ZZ; Gilbert JJ; Strejan GH
Cell Immunol; 1986 Apr; 99(1):265-78. PubMed ID: 2428529
[TBL] [Abstract][Full Text] [Related]
36. Experimental allergic encephalomyelitis in guinea pig: variability of response to intradermal emulsion injection.
Gambi D; Di Cesare N; Di Trapani G; Macchi G; Sbriccoli A
Ital J Neurol Sci; 1989 Feb; 10(1):33-41. PubMed ID: 2925344
[TBL] [Abstract][Full Text] [Related]
37. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
[TBL] [Abstract][Full Text] [Related]
38. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs.
Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):635-8. PubMed ID: 6172501
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
Holda JH; Silberg D; Swanborg RH
J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant.
Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
